The GW Cancer Center is establishing a Stem Cell Transplantation and Cellular Therapy Program to provide state of the art standard of care to patients with malignant and non-malignant disorders requiring stem cell transplantation and develop novel cell based therapies to treat cancer.
We are seeking a quality assurance manager to establish the stem cell transplantation program and prepare it for accreditation by the Foundation for the Accreditation of Cellular Therapy (FACT) and to maintain Quality Assurance and Quality Control or the program thereafter. The Quality Assurance Manager for the GWCC Cellular Therapy Program (QA Manager) will be responsible for developing, implementing, monitoring, and maintaining the George Washington Cancer Center Stem Cell Transplant and Cellular Therapy Program (GWSCT) Quality Plan.
The QA Manager will primarily be responsible for program adherence to practices that ensure patient and staff safety, in compliance with the Foundation for the Accreditation of Cellular Therapy (FACT) as well as all state and federal regulations. The GWSCT is the adult stem cell transplantation program partner with the pediatric stem cell transplantation program at the Children’s National Medical Center Washington DC (CNMC). For the purposes of FACT accreditation these two programs report jointly to FACT and are jointly assessed by FACT. To achieve this pediatric/adult program collaboration the appointed QA manager will coordinate quality assurance practices and standard operating procedures in conjunction with the QA manager at CNMC.
The ideal candidate will possess one or more of the following qualifications:
• Bachelor of Science in Nursing • Nurse Practitioner (Master of Science in Nursing or Doctor of Nursing Practice) • Physician Assistant (Master of Physician Assistant) • Minimum of 2 years of relevant clinical experience in hematology/oncology, blood banking, or preferably stem cell transplant. • Experience working with the Foundation for the Accreditation of Cellular Therapy (FACT), the Center for International Blood and Marrow Transplant Research (CIBMTR), the National Marrow Donor Program (NMDP), and the Food and Drug Administration (FDA)